{"gene":"ETV2","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":2002,"finding":"ER71 is a constitutively nuclear protein whose intracellular localization depends on a portion of the ETS domain (amino acids 276-315). The N-terminus of ER71 negatively regulates DNA binding, while the C-terminus dramatically enhances DNA binding activity. ER71 possesses a potent N-terminal transactivation domain (amino acids 1-157) and directly activates the matrix metalloproteinase-1 promoter via an E74 site.","method":"Deletion mutagenesis, reporter assays, nuclear localization analysis","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro functional characterization with mutagenesis but single lab, single study","pmids":["12087183"],"is_preprint":false},{"year":2006,"finding":"TSGA/Jmjd1a interacts with ER71 both in vitro and in vivo; the N-terminus of TSGA and C-terminus of ER71 mediate complex formation. TSGA represses ER71-dependent transcriptional activation of the MMP-1 promoter.","method":"Co-immunoprecipitation, in vitro binding assay, reporter assay","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reciprocal binding shown in vitro and in vivo, functional consequence demonstrated, single lab","pmids":["16619273"],"is_preprint":false},{"year":2008,"finding":"ER71 acts downstream of BMP, Notch, and Wnt signaling to regulate FLK1+ mesoderm specification. Inhibition of BMP, Notch, and Wnt signaling decreased FLK1+ mesoderm and ER71 expression; enforced ER71 expression rescued FLK1+ mesoderm generation blocked by these inhibitors. Er71-deficient mice lacked FLK1 expression and displayed severe blood and vessel defects reminiscent of Flk1 null mice.","method":"Embryonic stem cell differentiation, pathway inhibition, genetic knockout, gain-of-function rescue","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple pathway inhibitors, loss-of-function, and gain-of-function rescue, replicated across multiple experimental systems","pmids":["18462699"],"is_preprint":false},{"year":2008,"finding":"Human ETV2/ER71 and mouse ER71 are functional orthologs of zebrafish Etsrp. Overexpression of mouse ER71 caused expansion of hemangioblast and vascular endothelial lineages in zebrafish. Etsrp functions cell-autonomously in inducing myeloid lineage, and the choice of endothelial versus myeloid fate depends on combinatorial effects of etsrp, scl, and alk8.","method":"Zebrafish overexpression, mosaic analysis, morpholino knockdown","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-autonomous function established by mosaic analysis, multiple orthogonal approaches, replicated across organisms","pmids":["18270322"],"is_preprint":false},{"year":2011,"finding":"Etv2 is dispensable for generating primitive Flk-1+/PDGFRα+ mesoderm but required for the progression of these cells into Flk-1+/PDGFRα- vascular/hematopoietic mesoderm. Key downstream targets include Scl, Fli1, and GATA2. Expression of Scl or Fli1 alone could restore HPCs/ECs in Etv2-null background. VEGF potently and rapidly induces Etv2 in Flk-1+ mesoderm.","method":"ESC differentiation, Etv2-null embryo analysis, re-expression rescue experiments, gene expression profiling","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — null embryo analysis combined with rescue experiments identifying specific downstream targets, multiple orthogonal approaches","pmids":["21911838"],"is_preprint":false},{"year":2011,"finding":"In the absence of ER71, cells that would normally become hematopoietic and endothelial lineages are redirected to cardiac lineages, including cardiomyocytes. ER71-expressing cells give rise to hematopoietic and endothelial lineages in wild-type, but contribute to cardiac lineage in Er71 mutants. ER71 overexpression repressed cardiogenesis.","method":"Er71-EYFP transgenic mouse, Er71-Cre genetic fate mapping, FACS, transcriptional profiling, inducible ES/EB system","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic fate mapping with Cre-lox, multiple engineered mouse models, and ESC system, orthogonal methods in single study","pmids":["21989919"],"is_preprint":false},{"year":2011,"finding":"Etsrp-expressing vascular endothelial/endocardial progenitors differentiate as cardiomyocytes in the absence of Etsrp function. Etsrp directly induces endocardial nfatc1 expression to regulate endocardial differentiation. Etsrp inhibits myocardial differentiation through a distinct mechanism from endocardial induction. Foxc1a interaction with Etsrp is required to initiate endocardial development but dispensable for inhibition of myocardial differentiation.","method":"Zebrafish morpholino knockdown, mutant analysis, lineage tracing","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function combined with direct target identification and dissection of two distinct regulatory mechanisms, replicated in multiple zebrafish models","pmids":["21989916"],"is_preprint":false},{"year":2011,"finding":"Foxc1a and Foxc1b directly regulate etsrp expression in angioblasts. ChIP showed Foxc1a/b binding to an enhancer 2.3 kb upstream of etsrp containing a consensus FOX binding site. Combined knockdown of foxc1a/b decreased etsrp expression at early developmental stages.","method":"EMSA, ChIP, morpholino knockdown, transgenic reporter analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct binding demonstrated by EMSA and ChIP, functional consequence shown by knockdown, two orthogonal methods","pmids":["22135404"],"is_preprint":false},{"year":2012,"finding":"ER71 specifies Flk-1+PDGFRα- hemangiogenic mesoderm by negatively regulating cardiac and Wnt signaling pathway genes. ER71 inhibits Wnt signaling through VE-cadherin-independent and VE-cadherin-dependent (VE-cadherin/β-catenin/Flk-1 complex formation) mechanisms. Enforced β-catenin rescued cardiogenic mesoderm in the context of ER71 overexpression.","method":"ESC differentiation, gain/loss-of-function, β-catenin rescue experiments, gene expression analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple genetic approaches establishing epistasis between ER71 and Wnt signaling, rescue experiments, single lab","pmids":["22343916"],"is_preprint":false},{"year":2012,"finding":"PKA/CREB signaling activates Etv2 transcription to trigger endothelial and hematopoietic cell differentiation. Two CRE sequences in the Etv2 promoter and 5'-UTR were identified; CREB directly binds these CRE sites. Dominant negative CREB completely inhibited PKA-elicited Etv2 expression and EC/HPC induction from ESCs.","method":"Promoter analysis, CREB binding confirmation, dominant-negative CREB, PKA inhibition, ex vivo embryo culture","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct binding demonstrated, functional consequence with dominant-negative approach, validated in vivo in Etv2-Venus knockin mice","pmids":["22267325"],"is_preprint":false},{"year":2012,"finding":"SRY binds to and activates the Er71 promoter. In turn, ER71 binds to the Sox9 promoter and activates Sox9 transcription; mutation of the ER71 binding site suppressed this activation. SOX9 also binds the Er71 promoter, and Sox9 downregulation reduced Er71 levels, forming a positive autoregulatory loop between ER71 and SOX9 in testis.","method":"Promoter binding assays, site-directed mutagenesis, dominant-negative ER71, ChIP, luciferase reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct promoter binding by ChIP and mutagenesis, functional consequence demonstrated with dominant-negative and knockdown, multiple orthogonal approaches","pmids":["22613723"],"is_preprint":false},{"year":2012,"finding":"ETV2 is required for the formation of hemogenic endothelium; ETV2 deficiency results in a complete absence of hemogenic endothelium in differentiating ES cells and gastrulating embryos.","method":"ETV2::GFP transgenic mouse, ES cell differentiation, FACS sorting, in vivo embryo analysis","journal":"Developmental dynamics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — transgenic reporter combined with ETV2 null analysis, two orthogonal systems (ES cells and embryos)","pmids":["22733530"],"is_preprint":false},{"year":2012,"finding":"ETV2 acts prior to or at the time of FLK1 expression in mesodermal precursors. ETV2 re-expression in Etv2-/- Flk1-negative precursors drives hematopoiesis specification and switches on SCL, GATA2, and FLI1 expression. SCL re-expression in Etv2-/- cells fully rescues hematopoiesis, while FLI1 or GATA2 re-expression provides only limited rescue.","method":"Cre-mediated ETV2 deletion, Flk1-Cre, ESC differentiation rescue experiments","journal":"Stem cells (Dayton, Ohio)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout combined with systematic rescue experiments identifying hierarchy of downstream targets, two independent laboratories (replicated findings)","pmids":["22570122"],"is_preprint":false},{"year":2013,"finding":"Etv2 expression alone is sufficient to transdifferentiate fast skeletal muscle cells into functional blood vessels in vivo. The canonical Wnt pathway is important for induction of transdifferentiation, while the VEGF pathway provides a maturation signal for endothelial fate. Mammalian myoblasts, but not other cell types examined, induced vascular gene expression upon Etv2 overexpression.","method":"Heat shock-inducible Etv2 zebrafish transgene, time-lapse imaging, lineage tracing, immunostaining, pharmacological/transgenic/morpholino approaches","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — lineage tracing confirms muscle-to-endothelial transdifferentiation, time-lapse imaging, multiple pathway dissection approaches in single rigorous study","pmids":["23853546"],"is_preprint":false},{"year":2013,"finding":"Forced expression of Etv2 rescued both hematopoietic and endothelial potential of differentiating Flk1-/- and Etv2-/- cells, whereas forced Flk1 expression rescued only Flk1-/- but not Etv2-/- cells. This demonstrates that Etv2 functions downstream of or parallel to Flk1 and that disruption of Etv2 expression is responsible for early phenotypes of Flk1 mutant embryos.","method":"Inducible viral rescue of knockout ESCs, EB differentiation","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis established by differential rescue experiments in two distinct null backgrounds, single lab","pmids":["23606617"],"is_preprint":false},{"year":2013,"finding":"Post-transcriptional repression by let-7 family microRNAs contributes to Etv2 downregulation during vascular development. The etv2 3'UTR contains binding sites for let-7 miRNAs; ectopic let-7a repressed the etv2 3'UTR and blocked endogenous Etv2 protein expression. Etv2 protein persisted in maternal-zygotic dicer1 mutant zebrafish embryos.","method":"Inducible Etv2 knockdown, 3'UTR reporter assays, miRNA overexpression, dicer1 mutant analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3'UTR reporter assay combined with dicer mutant validation, multiple orthogonal approaches, single lab","pmids":["24036310"],"is_preprint":false},{"year":2014,"finding":"Etv2 interacts with Gata2 in vitro and in vivo; the interaction is mediated by the Ets and Gata domains. Co-expression of Gata2 augments Etv2 activity in promoting endothelial and hematopoietic lineage differentiation. Etv2 and Gata2 both bind the Spi1 promoter in vitro and in vivo.","method":"Co-immunoprecipitation, GST pulldown, ChIP, embryoid body differentiation","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and GST pulldown with domain mapping, in vivo ChIP, functional co-expression data, multiple orthogonal methods","pmids":["24583263"],"is_preprint":false},{"year":2014,"finding":"Etv2 binds to conserved Ets-binding sites in the Fli1 promoter and governs Fli1 expression. After Etv2 expression ceases at midgestation, Fli1 protein itself binds those same Ets-binding sites in a positive autoregulatory loop, maintaining Fli1 expression and selective Etv2-regulated endothelial genes. Fli1 also binds the Tie2 promoter/enhancer to control its expression beyond midgestation.","method":"ChIP, promoter binding assays, loss/gain-of-function, endothelial cell survival assays","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct promoter binding by ChIP with functional consequence, ETS switching mechanism demonstrated, multiple molecular and cellular approaches","pmids":["24727028"],"is_preprint":false},{"year":2014,"finding":"OVOL2, a C2H2 zinc finger protein, directly interacts with ER71/ETV2 in the nucleus. OVOL2 enhances ER71-mediated activation of the Flk1 promoter. Co-expression of ER71 and OVOL2 augmented FLK1+, endothelial, and hematopoietic cell generation from differentiating ESCs.","method":"Co-immunoprecipitation, luciferase reporter assay, ESC differentiation, shRNA knockdown","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with functional reporter assay and shRNA validation, single lab","pmids":["25267199"],"is_preprint":false},{"year":2014,"finding":"ETV2 directly regulates Sox7 by binding ETV2 binding elements in the Sox7 upstream regulatory region and activating transcription. SOX7 overexpression mimics ETV2 in increasing endothelial progenitor cells, while Sox7 knockdown blocks ETV2-induced endothelial progenitor formation and angiogenic sprouting.","method":"ChIP, luciferase reporter assay, shRNA knockdown, embryoid body differentiation","journal":"Stem cells and development","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct binding by ChIP with mutagenesis-style reporter confirmation, functional epistasis by rescue/block, single lab","pmids":["24762086"],"is_preprint":false},{"year":2014,"finding":"FoxC2 and Etv2 cooperatively activate a FOX:ETS composite motif in the ECE1 arterial enhancer. Additionally, Sox17 binds a conserved SOX site in the same enhancer, and the ECE1 enhancer is cooperatively activated by combinatorial action of FoxC2, Etv2, and Sox17.","method":"Transgenic mouse reporter assay, EMSA, promoter mutagenesis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vivo reporter combined with in vitro binding, cooperative activation demonstrated with mutagenesis, single lab","pmids":["25179465"],"is_preprint":false},{"year":2015,"finding":"ETV2 binds to enhancers that specify hematopoietic and endothelial cell lineages (global ChIP-seq). ETV2 activates other Ets genes (Fli1, Erg, etc.), establishing an ETS hierarchy, and the hematopoietic/endothelial program initiated by ETV2 is maintained by other ETS factors through an ETS switching mechanism. The hemangiogenic progenitor population (FLK1highPDGFRα-) is exclusively sensitive to ETV2-dependent FLK1 signaling.","method":"ChIP-seq, ESC differentiation, germ-line and conditional knockout mouse studies","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 / Strong — genome-wide ChIP-seq with multiple genetic models (in vitro and in vivo), multiple orthogonal methods establishing ETS hierarchy mechanism","pmids":["25802403"],"is_preprint":false},{"year":2015,"finding":"Etv2 and Fli1b share the same transcriptional targets and bind to the same ETS sites, as shown by RNA-Seq and ChIP. Etv2 and Fli1b function redundantly during late vasculogenesis and early embryonic angiogenesis, with two distinct phases: Etv2 alone required for early vasculogenesis, Etv2 and Fli1b redundant during late vasculogenesis/early angiogenesis.","method":"Zebrafish mutants, RNA-Seq, ChIP, photoactivatable morpholinos, overexpression","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — shared target identification by ChIP and RNA-Seq combined with genetic epistasis, multiple orthogonal approaches in single study","pmids":["25722433"],"is_preprint":false},{"year":2015,"finding":"Etv2 directly activates miR-130a. miR-130a promotes the endothelial program at the expense of cardiac program by directly suppressing Pdgfra expression and blocking Pdgfra signaling. CRISPR/Cas9 knockout of miR-130a reduced the endothelial program without affecting hematopoiesis.","method":"ChIP, CRISPR/Cas9 knockout, gain-of-function, Dicer ablation in Etv2-expressing cells, ESC/EB differentiation","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct ChIP target validation combined with CRISPR knockout and rescue experiments, multiple orthogonal approaches","pmids":["26565905"],"is_preprint":false},{"year":2015,"finding":"Endothelial ETV2 is required for injury-induced vascular regeneration. Etv2 expression is reactivated in endothelial cells after injury (but not detectable at steady-state). ETV2 upregulates Flk1/VEGFR2 expression after injury; Flk1 expression rescued angiogenesis defects in endothelial Etv2 conditional knockout mice. Etv2+/-;Flk1+/- double heterozygous mice showed more severe ischemic injury response, establishing epistatic interaction between ETV2 and FLK1.","method":"Endothelial-specific conditional knockout, ischemia models, lentiviral rescue, double heterozygous epistasis","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with multiple ischemia models, lentiviral rescue, and genetic epistasis, multiple orthogonal approaches","pmids":["26586661"],"is_preprint":false},{"year":2015,"finding":"LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2. Hematopoietic defects in lsd1 mutant zebrafish were rescued by knockdown of etv2, placing LSD1 upstream of Etv2 in hemangioblast fate commitment.","method":"Zebrafish mutant screen, morpholino knockdown rescue, genetic epistasis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via rescue experiment, morpholino knockdown in mutant background, single lab","pmids":["26512114"],"is_preprint":false},{"year":2017,"finding":"Vegf signaling promotes vascular endothelial differentiation by modulating Etv2 expression. Vegfr inhibition reduced etv2 expression; Vegfaa overexpression expanded etv2 expression. Vascular-specific overexpression of etv2 in Vegfr-inhibited embryos rescued defects in vascular endothelial differentiation, placing Etv2 downstream of Vegf signaling.","method":"Chemical Vegfr inhibition, genetic mutants, overexpression rescue, zebrafish embryos","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and pharmacological approaches combined with rescue experiment establishing Etv2 as downstream target of Vegf, replicated across chemical and genetic models","pmids":["28279709"],"is_preprint":false},{"year":2017,"finding":"ETV2 directly binds promoter region of Rhoj, serving as upstream transcriptional regulator of cell migration. ETV2 overexpression enhanced cell migration in ESCs, embryoid bodies, and fibroblasts; Etv2 knockout led to migratory defects of angioblasts in developing embryos. shRNA knockdown of Rhoj caused migration defects partially rescued by ETV2 overexpression.","method":"ChIP-seq, ATAC-seq, RNAseq, migration assays, Etv2 knockout embryos, shRNA knockdown rescue","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ChIP-seq and ATAC-seq with direct functional validation in multiple cell systems and in vivo, multiple orthogonal methods in single study","pmids":["33115267"],"is_preprint":false},{"year":2017,"finding":"IP3R-mediated Ca2+ signals govern hematopoietic versus cardiac fate of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway. Constitutively active NFATc3 rescued Etv2 expression in IP3R-knockout cells. NFATc3 directly targets Etv2 via an evolutionarily conserved cis-element.","method":"IP3R triple knockout ESCs, Ca2+ manipulation, calcineurin activation, NFATc3 constitutively active expression, ChIP","journal":"Journal of molecular cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway epistasis established with knockout and rescue, direct binding by ChIP, single lab","pmids":["28419336"],"is_preprint":false},{"year":2017,"finding":"Foxh1, in part through Eomes, is critical for FLK1+ mesoderm formation. Hemangiogenic fate is specified through a threshold-dependent mechanism in which VEGF-FLK1 signaling plays an instructive role by promoting Etv2 threshold expression.","method":"Genome-wide CRISPR screen, Brachyury/Etv2/Scl reporter ESC lines, transcriptome analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — unbiased genome-wide CRISPR screen with reporter lines and transcriptome validation, establishes upstream pathway, single lab","pmids":["28912455"],"is_preprint":false},{"year":2018,"finding":"ETV2 is sufficient and necessary for transdifferentiation of CD133+/Nestin+ GBM/neural stem cells to endothelial lineage. ChIP-Seq combined with gain-of-function RNA-Seq showed that ETV2 activates vascular genes and represses proneural genes to direct endo-transdifferentiation. This process is VEGF-A independent.","method":"ChIP-Seq, RNA-Seq, gain/loss-of-function experiments","journal":"Signal transduction and targeted therapy","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — ChIP-seq and RNA-seq combined with functional gain/loss-of-function, single lab","pmids":["29527330"],"is_preprint":false},{"year":2018,"finding":"ETV2 directly binds promoter/enhancer regions of Vegfr3/Flt4 and lymphatic marker Lyve1, promoting their expression. Etv2 inhibition at 1 dpf inhibited lymphangiogenesis while blood vessel development was unaffected, and lymphatic progenitors failed to respond to Vegfc signaling in Etv2-deficient embryos.","method":"Photoactivatable morpholinos, ChIP-seq, luciferase reporter assays, zebrafish embryos","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ChIP-seq with direct reporter validation and inducible knockdown, multiple orthogonal methods in single study","pmids":["29753018"],"is_preprint":false},{"year":2018,"finding":"ETV2 directly interacts with TET1 and TET2 methylcytosine-converting enzymes. ETV2 binds ETS motifs in the Robo4 promoter and activates expression. ETV2-TET1/TET2 complexes demethylate the Robo4 promoter in non-endothelial cells, providing a mechanism for EC-specific gene expression via promoter demethylation.","method":"Co-immunoprecipitation, reporter assay, adenoviral expression, methylation analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP of complex with functional consequence in DNA demethylation, two orthogonal approaches, single lab","pmids":["29618782"],"is_preprint":false},{"year":2019,"finding":"cAMP/EPAC/RAP1 signaling facilitates ETV2-mediated endothelial transdifferentiation. ChIP-seq showed majority of ETV2 targets in human fibroblasts are related to vasculature development and Rap1 signaling. Activation of cAMP/EPAC/RAP1 axis improved efficiency and quality of ETV2-induced endothelial cells.","method":"ChIP-seq, pharmacological pathway activation, in vivo and in vitro functional assays","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — ChIP-seq with pharmacological pathway validation, functional assessment, single lab","pmids":["31864907"],"is_preprint":false},{"year":2019,"finding":"ETV2 transcriptionally regulates Yes1 as a direct upstream regulator during embryogenesis. Doxycycline-mediated Etv2 induction increased Yes1 in a dose-dependent manner. Etv2 induction also caused ~2.5-fold increase in cellular proliferation, associated with upregulation of cell cycle genes E2f4 and Ccne1.","method":"ChIP-seq analysis, RNAseq, EdU-incorporation, doxycycline-inducible Etv2 ES/EB system, single-cell RNA-seq","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — ChIP-seq identifying direct binding to Yes1 promoter with dose-dependent expression validation and null EB confirmation, multiple orthogonal methods, single lab","pmids":["31278282"],"is_preprint":false},{"year":2019,"finding":"ETV2/ER71 directly induces miR-126, which positively regulates FLK1+ cell generation by activating the MAPK pathway through targeting SPRED1. JUN/FOS activate the FLK1 enhancer through AP1 binding sequences downstream of this miR-126-MAPK axis.","method":"miRNA sequencing, ChIP-PCR, signaling pathway analysis","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — ChIP-PCR establishing direct miR-126 target with downstream MAPK pathway validation, single lab","pmids":["31744543"],"is_preprint":false},{"year":2022,"finding":"ETV2 functions as a pioneer factor that binds nucleosomal DNA and recruits BRG1. BRG1 recruitment remodels chromatin around endothelial genes and helps maintain an open configuration, resulting in increased H3K27ac deposition, thereby regulating endothelial development.","method":"Multi-omics (ATAC-seq, ChIP-seq), engineered ESC differentiation and reprogramming models, nucleosome binding assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — nucleosome binding shown directly, BRG1 recruitment mechanism validated, chromatin remodeling quantified by multiple epigenomic methods in a rigorous multi-omics study","pmids":["35550615"],"is_preprint":false},{"year":2022,"finding":"ETV2 functions as a pioneer transcription factor initiating Shh expression during limb development by changing chromatin status of the ZRS limb enhancer. ETV2 binds nucleosome-occupied ZRS, causes nucleosomal displacement at ETS binding site clusters, and is antagonized by ETV4/5 repressors. Known human polydactyl mutations introduce novel ETV2 binding sites in the ZRS.","method":"Etv2 conditional inactivation, Etv2 overexpression in limb buds, ATAC-seq, ChIP-seq, luciferase reporter assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — pioneer factor activity directly demonstrated with chromatin accessibility assays and nucleosome displacement analysis, combined with gain/loss-of-function in vivo, multiple orthogonal methods","pmids":["35864091"],"is_preprint":false},{"year":2022,"finding":"Etv2 dosage determines fate between hemogenic and aortic endothelium from a common hemogenic angioblast precursor. High Etv2 dosage specifies hemogenic endothelial cells while low Etv2 specifies conventional endothelium.","method":"Photoconvertible labeling, time-lapse imaging, single-cell RNA-sequencing, zebrafish","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — lineage tracing with photoconversion combined with scRNA-seq, single lab, two orthogonal approaches","pmids":["35333649"],"is_preprint":false},{"year":2022,"finding":"Etv2 functions directly in a coherent feedforward transcriptional network for vascular endothelial development. Low-level Etv2 expression is sufficient to induce and sustain the endothelial GRN, whereas a significantly higher threshold of Etv2 is required to initiate and sustain erythropoietic development. Etv2 induces the erythropoietic GRN indirectly via activation of Tal1.","method":"Hypomorphic Etv2 mutant analysis, gene regulatory network analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — hypomorphic mutant provides dosage-sensitive mechanistic insight, identifies Tal1 as indirect effector, single lab","pmids":["35649376"],"is_preprint":false},{"year":2022,"finding":"Bmp signalling acts upstream of etv2 in regulating endocardial identity in zebrafish. Overactivation of Bmp signalling was unable to restore endocardial expression in etv2 mutants, but overexpression of etv2 rescued endocardial expression upon Bmp inhibition, establishing etv2 downstream of Bmp.","method":"Zebrafish etv2 and npas4l mutants, Bmp gain/loss of function, epistasis experiments","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with reciprocal rescue experiments, single lab","pmids":["35531980"],"is_preprint":false},{"year":2023,"finding":"ETV2 directly interacts with VEZF1 (vascular endothelial zinc finger 1), as demonstrated by yeast two-hybrid, co-immunoprecipitation, and GST pulldown. VEZF1 co-activates ETV2-dependent Flt1 promoter activity. VEZF1 binds the Flt1 promoter in vitro and in vivo (EMSA and ChIP).","method":"Yeast two-hybrid, co-immunoprecipitation, GST pulldown, luciferase reporter, EMSA, ChIP, Vezf1 knockout ESCs","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct interaction confirmed by three independent binding assays, functional consequence by reporter and knockout, multiple orthogonal methods in single study","pmids":["36923254"],"is_preprint":false},{"year":2023,"finding":"ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment. ETV2 binding at hematoendothelial regulator genes precedes transcriptional activation; the shift from ETV2 binding to ETV2-bound enhancer activation drives hematoendothelial fate commitment.","method":"scRNA-seq, ATAC-seq, chromatin accessibility analysis of fate intermediates in mouse","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — chromatin and transcriptome profiling in isolated fate intermediates, mechanistic distinction between binding and activation events, single lab","pmids":["37330911"],"is_preprint":false},{"year":2024,"finding":"ETV2 interacts with KDM4A, an H3K9 demethylase; Etv2-null ESCs exhibit enhanced H3K9me3 levels at hematopoietic and endothelial genes. ETV2-mediated transcriptional activation of hematopoietic and endothelial genes depends on KDM4A histone demethylase activity. Cdh5Cre:Kdm4a;Etv2 double conditional knockout mice show more severe vascular regeneration defects than single knockouts.","method":"Co-immunoprecipitation, H3K9me3 ChIP, conditional double knockout mice, vascular perfusion assays","journal":"iScience","confidence":"High","confidence_rationale":"Tier 1 / Moderate — Co-IP of complex, direct epigenetic consequence in null cells, genetic validation by double conditional knockout with additive phenotype, multiple orthogonal methods","pmids":["39811655"],"is_preprint":false},{"year":2024,"finding":"BCL6B binds the promoter region of ETV2 and suppresses ETV2's transcriptional activity, thereby inhibiting endothelial cell differentiation from hiPSCs. ETV2 overexpression rescued the inhibitory effect of BCL6B overexpression on EC differentiation.","method":"Luciferase reporter assay, ChIP-PCR, doxycycline-inducible hiPSC systems, rescue experiments","journal":"Stem cell research & therapy","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct promoter binding by ChIP-PCR with reporter validation and rescue experiment, single lab","pmids":["39075623"],"is_preprint":false},{"year":2025,"finding":"ETV2 pioneer activity both directs EC specification and suppresses alternative fate acquisition. ETV2 recruits the transcriptional repressor REST to repress non-EC lineage genes. GABPA is identified as a cofactor essential for efficient EC specification downstream of ETV2.","method":"CUT&RUN, scRNA-seq, scATAC-seq, functional screening, candidate validation","journal":"Nature cardiovascular research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — single-cell multi-omics combined with functional screening and candidate validation identifies ETV2-REST recruitment mechanism, multiple orthogonal methods in single rigorous study","pmids":["40495012"],"is_preprint":false},{"year":2017,"finding":"Etv2 transcriptionally regulates miR-130a-Jarid2: Etv2-Cre Dicer ablation disrupts vascular patterning. miR-130a directly regulates Jarid2 expression by binding its 3'-UTR, promoting angiogenesis. Jarid2 overexpression leads to defective tube formation; miR-130a morpholino injection in zebrafish results in perturbed vascular patterning with increased Jarid2 levels.","method":"Etv2-Cre DicerL/L, miR-130a overexpression, Jarid2 3'UTR binding, zebrafish morpholinos, HUVEC tube formation","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — 3'UTR binding validated with morpholino rescue, in vitro and in vivo validation, single lab","pmids":["29232705"],"is_preprint":false},{"year":2024,"finding":"PPARγ transcriptionally activates the ETV2 promoter. Endothelial PPARγ overexpression increases ETV2 expression and endothelial markers, while PPARγ knockout decreases ETV2 expression. Etv2 haploinsufficient mice spontaneously developed pulmonary hypertension and right ventricular hypertrophy with increased EndoMT markers.","method":"Promoter reporter assay, conditional knockout/overexpression mouse models, EndoMT model","journal":"Pulmonary circulation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter activation confirmed with matching in vivo genetic models, single lab","pmids":["39391221"],"is_preprint":false}],"current_model":"ETV2/ER71 is a pioneer ETS transcription factor that acts as a master regulator of hematoendothelial lineage specification: it binds nucleosomal DNA at closed chromatin, recruits chromatin remodelers (BRG1, KDM4A) and the repressor REST to simultaneously open endothelial/hematopoietic gene enhancers and silence alternative lineage genes; it is activated downstream of BMP/Notch/Wnt, VEGF-FLK1, PKA/CREB, and Ca2+-calcineurin-NFATc3 signals, cooperates with co-factors including GATA2, OVOL2, FoxC2, VEZF1, and SOX17 on target enhancers, establishes an ETS hierarchy by directly activating Fli1, Scl, GATA2, and Sox7, and is itself subject to post-transcriptional repression by let-7 microRNAs; its transient expression is critical, as persistent ETV2 perturbs vascular development, while reactivation after injury drives vascular regeneration via upregulation of FLK1/VEGFR2."},"narrative":{"mechanistic_narrative":"ETV2/ER71 is a pioneer ETS transcription factor that acts as a master regulator of hematoendothelial lineage specification, governing the progression of FLK1+ mesoderm into vascular and hematopoietic fates while suppressing alternative cardiac fate [PMID:18462699, PMID:21911838, PMID:21989919]. As a pioneer factor it binds nucleosomal DNA at otherwise closed chromatin, displaces nucleosomes at clustered ETS sites, and recruits the BRG1 chromatin remodeler to open and maintain endothelial gene enhancers with increased H3K27ac [PMID:35550615, PMID:35864091]. It primes hematoendothelial enhancers ahead of transcriptional activation, and the transition from binding to enhancer activation drives fate commitment [PMID:37330911]. ETV2 partners with chromatin- and DNA-modifying enzymes—the H3K9 demethylase KDM4A to relieve repressive H3K9me3 at target genes, and TET1/TET2 to demethylate promoters such as Robo4 for endothelial-specific expression—and it recruits the repressor REST to silence non-endothelial lineage genes [PMID:39811655, PMID:29618782, PMID:40495012]. ETV2 establishes an ETS hierarchy by directly activating downstream regulators including Scl/Tal1, Fli1, GATA2, Erg, and Sox7, with the program subsequently maintained by Fli1 through ETS switching after ETV2 expression ceases [PMID:25802403, PMID:21911838, PMID:24727028, PMID:24762086]. It cooperates with co-factors GATA2, OVOL2, FoxC2/Sox17, and VEZF1 on target enhancers to drive endothelial and hematopoietic gene activation [PMID:24583263, PMID:25267199, PMID:25179465, PMID:36923254]. ETV2 is activated downstream of BMP/Notch/Wnt, VEGF-FLK1, PKA/CREB, and calcineurin–NFATc3 signaling, and it dose-dependently partitions endothelial versus hematopoietic/hemogenic fate [PMID:18462699, PMID:28279709, PMID:22267325, PMID:28419336, PMID:35333649, PMID:35649376]. Its expression is transient, terminated post-transcriptionally by let-7 microRNAs, and its reactivation in endothelium after injury drives vascular regeneration via upregulation of FLK1/VEGFR2 [PMID:24036310, PMID:26586661].","teleology":[{"year":2002,"claim":"Established the basic molecular architecture of ER71 as a nuclear ETS transcriptional activator before its developmental role was known.","evidence":"Deletion mutagenesis and reporter assays mapping localization, DNA-binding, and transactivation domains on the MMP-1 promoter","pmids":["12087183"],"confidence":"Medium","gaps":["No developmental or lineage function identified","MMP-1 target not connected to vascular biology"]},{"year":2006,"claim":"Identified the first ER71 protein partner, showing its activity is subject to negative regulation by an interacting protein.","evidence":"Reciprocal in vitro and in vivo binding with TSGA/Jmjd1a plus reporter repression","pmids":["16619273"],"confidence":"Medium","gaps":["Functional relevance to lineage specification not tested","Single lab"]},{"year":2008,"claim":"Defined ETV2 as a master mesodermal regulator downstream of BMP/Notch/Wnt and conserved across vertebrates, answering where it sits in lineage specification.","evidence":"ESC differentiation with pathway inhibition/rescue, mouse knockout, and zebrafish ortholog overexpression/mosaic analysis","pmids":["18462699","18270322"],"confidence":"High","gaps":["Direct chromatin targets not yet identified","Mechanism of transcriptional activation undefined"]},{"year":2011,"claim":"Resolved the precise developmental window and downstream effectors, showing ETV2 drives FLK1+ mesoderm into vascular/hematopoietic fate while repressing cardiac fate.","evidence":"Null embryo analysis, genetic fate mapping, and rescue identifying Scl, Fli1, GATA2 as effectors; zebrafish lineage tracing of endocardial nfatc1 induction","pmids":["21911838","21989919","21989916"],"confidence":"High","gaps":["Whether targets are bound directly versus indirectly not fully resolved","Chromatin-level mechanism unknown"]},{"year":2012,"claim":"Placed ETV2 within upstream signaling and feedback circuits, establishing how VEGF-FLK1, PKA/CREB, and Wnt converge on its expression and activity.","evidence":"Promoter/CRE binding analysis with dominant-negative CREB, beta-catenin rescue of ER71-suppressed cardiogenesis, GFP reporter null analysis of hemogenic endothelium","pmids":["22343916","22267325","22733530","22570122"],"confidence":"High","gaps":["Genome-wide binding landscape not yet defined","Hierarchy among downstream targets only partially ordered"]},{"year":2014,"claim":"Assembled the ETV2 cofactor network and the ETS-switching maintenance mechanism, explaining how a transient factor establishes a self-sustaining program.","evidence":"Co-IP/GST pulldown with GATA2 and OVOL2, ChIP of Fli1/Sox7 promoters, FOX:ETS composite enhancer cooperativity with FoxC2/Sox17","pmids":["24583263","25267199","24727028","24762086","25179465"],"confidence":"High","gaps":["How cofactor combinations are selected at specific enhancers unknown","Stoichiometry of complexes undefined"]},{"year":2015,"claim":"Defined the genome-wide ETV2 enhancer program and its role in injury-induced regeneration, and identified microRNA effectors and upstream epigenetic regulators.","evidence":"ChIP-seq establishing ETS hierarchy, conditional knockout/ischemia models with FLK1 rescue and epistasis, miR-130a CRISPR knockout, LSD1 epistasis in zebrafish","pmids":["25802403","25722433","26565905","26586661","26512114"],"confidence":"High","gaps":["Pioneer activity not yet directly demonstrated","Chromatin remodeler partners not yet identified"]},{"year":2017,"claim":"Extended ETV2 function to cell migration, lymphatic and proliferation programs, and identified additional upstream signals (Ca2+-NFATc3, VEGF, Foxh1) controlling threshold expression.","evidence":"ChIP-seq/ATAC-seq of Rhoj and Yes1, IP3R-NFATc3 knockout/rescue, VEGF inhibition/rescue in zebrafish, genome-wide CRISPR screen","pmids":["33115267","28419336","28279709","28912455","29232705"],"confidence":"High","gaps":["Mechanism by which ETV2 dose is converted to distinct fates unresolved","Direct versus indirect nature of some targets unclear"]},{"year":2018,"claim":"Demonstrated ETV2 partners with DNA-modifying enzymes and can reprogram non-endothelial cells, revealing an epigenetic basis for endothelial-specific gene activation.","evidence":"Co-IP with TET1/TET2 and Robo4 promoter demethylation, ChIP-seq/RNA-seq of GBM/neural stem cell transdifferentiation, ChIP-seq of Vegfr3/Lyve1 lymphatic targets","pmids":["29618782","29527330","29753018"],"confidence":"Medium","gaps":["Direct demonstration of nucleosome engagement still lacking","Generality of TET recruitment across targets untested"]},{"year":2022,"claim":"Directly established ETV2 as a pioneer factor that engages nucleosomal DNA and recruits chromatin remodelers, the central mechanistic insight unifying its lineage-instructive activity.","evidence":"Nucleosome binding assays, ATAC-seq/ChIP-seq with BRG1 recruitment in ESC models, ZRS limb enhancer nucleosome displacement, dosage and feedforward network analysis","pmids":["35550615","35864091","35333649","35649376","35531980"],"confidence":"High","gaps":["Determinants of pioneer site selection genome-wide unresolved","How BRG1 recruitment is targeted not fully defined"]},{"year":2023,"claim":"Showed ETV2 primes enhancers prior to activation and identified VEZF1 as a direct cofactor, separating chromatin binding from transcriptional output.","evidence":"scRNA-seq/ATAC-seq of fate intermediates, yeast two-hybrid/Co-IP/GST pulldown with VEZF1 and Flt1 reporter/knockout","pmids":["37330911","36923254"],"confidence":"Medium","gaps":["Trigger converting primed enhancers to active state unknown","Single lab for VEZF1 interaction"]},{"year":2024,"claim":"Defined how ETV2 simultaneously activates target genes via KDM4A demethylation and is itself controlled by transcriptional regulators, with disease relevance in pulmonary hypertension.","evidence":"Co-IP and H3K9me3 ChIP with KDM4A double conditional knockouts, BCL6B repression in hiPSCs, PPARgamma promoter activation with Etv2 haploinsufficient pulmonary hypertension model","pmids":["39811655","39075623","39391221"],"confidence":"Medium","gaps":["Whether KDM4A is broadly required at all ETV2 targets unknown","Causal mechanism linking Etv2 haploinsufficiency to pulmonary hypertension incomplete"]},{"year":2025,"claim":"Established that ETV2 pioneer activity both activates endothelial genes and actively represses alternative fates by recruiting REST, with GABPA as a downstream cofactor.","evidence":"CUT&RUN, scRNA-seq, scATAC-seq, and functional screening with candidate validation","pmids":["40495012"],"confidence":"High","gaps":["Mechanism of REST recruitment by ETV2 undefined","Genome-wide repressive target set not exhaustively mapped"]},{"year":null,"claim":"How ETV2 dose, cofactor availability, and chromatin state are integrated to deterministically partition individual cells between endothelial, hemogenic, and hematopoietic fates remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No single-cell mechanistic model linking ETV2 dose to fate choice","Rules governing pioneer site selection unknown","Order and dependency of remodeler/demethylase/repressor recruitment undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,17,21,36]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,21,36,37]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[36,37]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,18]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4,5,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[17,21,36]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[36,37,43,45]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,26,28]}],"complexes":[],"partners":["GATA2","OVOL2","VEZF1","KDM4A","TET1","TET2","BRG1","REST"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O00321","full_name":"ETS translocation variant 2","aliases":["Ets-related protein 71"],"length_aa":342,"mass_kda":36.6,"function":"Binds to DNA sequences containing the consensus pentanucleotide 5'-CGGA[AT]-3'","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O00321/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ETV2","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ETV2","total_profiled":1310},"omim":[{"mim_id":"609358","title":"ETS VARIANT TRANSCRIPTION FACTOR 2; ETV2","url":"https://www.omim.org/entry/609358"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"testis","ntpm":18.2}],"url":"https://www.proteinatlas.org/search/ETV2"},"hgnc":{"alias_symbol":["ER71"],"prev_symbol":[]},"alphafold":{"accession":"O00321","domains":[{"cath_id":"1.10.10.10","chopping":"244-321","consensus_level":"high","plddt":93.22,"start":244,"end":321}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00321","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00321-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00321-F1-predicted_aligned_error_v6.png","plddt_mean":55.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ETV2","jax_strain_url":"https://www.jax.org/strain/search?query=ETV2"},"sequence":{"accession":"O00321","fasta_url":"https://rest.uniprot.org/uniprotkb/O00321.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00321/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00321"}},"corpus_meta":[{"pmid":"18462699","id":"PMC_18462699","title":"ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification.","date":"2008","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/18462699","citation_count":278,"is_preprint":false},{"pmid":"25540418","id":"PMC_25540418","title":"ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25540418","citation_count":169,"is_preprint":false},{"pmid":"21911838","id":"PMC_21911838","title":"Etv2/ER71 induces vascular mesoderm from Flk1+PDGFRα+ primitive mesoderm.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21911838","citation_count":146,"is_preprint":false},{"pmid":"32832668","id":"PMC_32832668","title":"Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32832668","citation_count":115,"is_preprint":false},{"pmid":"28003219","id":"PMC_28003219","title":"Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2.","date":"2016","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/28003219","citation_count":113,"is_preprint":false},{"pmid":"18270322","id":"PMC_18270322","title":"Interplay among Etsrp/ER71, Scl, and Alk8 signaling controls endothelial and myeloid cell formation.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18270322","citation_count":99,"is_preprint":false},{"pmid":"21989919","id":"PMC_21989919","title":"ER71 directs mesodermal fate decisions during embryogenesis.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21989919","citation_count":98,"is_preprint":false},{"pmid":"25802403","id":"PMC_25802403","title":"Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2.","date":"2015","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/25802403","citation_count":94,"is_preprint":false},{"pmid":"32094659","id":"PMC_32094659","title":"Generation of human endothelium in pig embryos deficient in ETV2.","date":"2020","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32094659","citation_count":85,"is_preprint":false},{"pmid":"21989916","id":"PMC_21989916","title":"Vascular endothelial and endocardial progenitors differentiate as cardiomyocytes in the absence of Etsrp/Etv2 function.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21989916","citation_count":83,"is_preprint":false},{"pmid":"22343916","id":"PMC_22343916","title":"ER71 specifies Flk-1+ hemangiogenic mesoderm by inhibiting cardiac mesoderm and Wnt signaling.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22343916","citation_count":71,"is_preprint":false},{"pmid":"16619273","id":"PMC_16619273","title":"Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16619273","citation_count":65,"is_preprint":false},{"pmid":"28279709","id":"PMC_28279709","title":"Vegf signaling promotes vascular endothelial differentiation by modulating etv2 expression.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28279709","citation_count":55,"is_preprint":false},{"pmid":"35550615","id":"PMC_35550615","title":"ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35550615","citation_count":51,"is_preprint":false},{"pmid":"25722433","id":"PMC_25722433","title":"Etv2 and fli1b function together as key regulators of vasculogenesis and angiogenesis.","date":"2015","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25722433","citation_count":51,"is_preprint":false},{"pmid":"26586661","id":"PMC_26586661","title":"Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2.","date":"2015","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26586661","citation_count":51,"is_preprint":false},{"pmid":"24583263","id":"PMC_24583263","title":"Cooperative interaction of Etv2 and Gata2 regulates the development of endothelial and hematopoietic lineages.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24583263","citation_count":51,"is_preprint":false},{"pmid":"26694034","id":"PMC_26694034","title":"The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development.","date":"2015","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/26694034","citation_count":50,"is_preprint":false},{"pmid":"22570122","id":"PMC_22570122","title":"The Flk1-Cre-mediated deletion of ETV2 defines its narrow temporal requirement during embryonic hematopoietic development.","date":"2012","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/22570122","citation_count":48,"is_preprint":false},{"pmid":"22135404","id":"PMC_22135404","title":"Etsrp/Etv2 is directly regulated by Foxc1a/b in the zebrafish angioblast.","date":"2011","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/22135404","citation_count":47,"is_preprint":false},{"pmid":"23853546","id":"PMC_23853546","title":"Transdifferentiation of fast skeletal muscle into functional endothelium in vivo by transcription factor Etv2.","date":"2013","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/23853546","citation_count":45,"is_preprint":false},{"pmid":"20235229","id":"PMC_20235229","title":"ETS family protein ETV2 is required for initiation of the endothelial lineage but not the hematopoietic lineage in the Xenopus embryo.","date":"2010","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/20235229","citation_count":44,"is_preprint":false},{"pmid":"32493965","id":"PMC_32493965","title":"Single-cell transcriptomic analysis identifies the conversion of zebrafish Etv2-deficient vascular progenitors into skeletal muscle.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32493965","citation_count":41,"is_preprint":false},{"pmid":"22267325","id":"PMC_22267325","title":"PKA/CREB signaling triggers initiation of endothelial and hematopoietic cell differentiation via Etv2 induction.","date":"2012","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/22267325","citation_count":41,"is_preprint":false},{"pmid":"24727028","id":"PMC_24727028","title":"Fli1 acts downstream of Etv2 to govern cell survival and vascular homeostasis via positive autoregulation.","date":"2014","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/24727028","citation_count":39,"is_preprint":false},{"pmid":"22733530","id":"PMC_22733530","title":"ETV2 expression marks blood and endothelium precursors, including hemogenic endothelium, at the onset of blood development.","date":"2012","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/22733530","citation_count":38,"is_preprint":false},{"pmid":"26512114","id":"PMC_26512114","title":"LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26512114","citation_count":38,"is_preprint":false},{"pmid":"12087183","id":"PMC_12087183","title":"Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12087183","citation_count":36,"is_preprint":false},{"pmid":"28781077","id":"PMC_28781077","title":"Embryonic Stem Cell Differentiation to Functional Arterial Endothelial Cells through Sequential Activation of ETV2 and NOTCH1 Signaling by HIF1α.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28781077","citation_count":36,"is_preprint":false},{"pmid":"29527330","id":"PMC_29527330","title":"ETV2 mediates endothelial transdifferentiation of glioblastoma.","date":"2018","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29527330","citation_count":33,"is_preprint":false},{"pmid":"22613723","id":"PMC_22613723","title":"Transcription factors ER71/ETV2 and SOX9 participate in a positive feedback loop in fetal and adult mouse testis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22613723","citation_count":32,"is_preprint":false},{"pmid":"29191922","id":"PMC_29191922","title":"Adventitial Sca1+ Cells Transduced With ETV2 Are Committed to the Endothelial Fate and Improve Vascular Remodeling After Injury.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29191922","citation_count":32,"is_preprint":false},{"pmid":"27137655","id":"PMC_27137655","title":"ETS Transcription Factor ETV2/ER71/Etsrp in Hematopoietic and Vascular Development.","date":"2016","source":"Current topics in developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/27137655","citation_count":31,"is_preprint":false},{"pmid":"22659386","id":"PMC_22659386","title":"Endothelialization and altered hematopoiesis by persistent Etv2 expression in mice.","date":"2012","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/22659386","citation_count":31,"is_preprint":false},{"pmid":"15780752","id":"PMC_15780752","title":"Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter.","date":"2005","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15780752","citation_count":30,"is_preprint":false},{"pmid":"28181481","id":"PMC_28181481","title":"Dpath software reveals hierarchical haemato-endothelial lineages of Etv2 progenitors based on single-cell transcriptome analysis.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28181481","citation_count":28,"is_preprint":false},{"pmid":"28912455","id":"PMC_28912455","title":"A CRISPR screen identifies genes controlling Etv2 threshold expression in murine hemangiogenic fate commitment.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28912455","citation_count":28,"is_preprint":false},{"pmid":"24036310","id":"PMC_24036310","title":"Post-transcriptional mechanisms contribute to Etv2 repression during vascular development.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24036310","citation_count":27,"is_preprint":false},{"pmid":"21425416","id":"PMC_21425416","title":"The Er71 is an important regulator of hematopoietic stem cells in adult mice.","date":"2011","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/21425416","citation_count":27,"is_preprint":false},{"pmid":"25179465","id":"PMC_25179465","title":"An arterial-specific enhancer of the human endothelin converting enzyme 1 (ECE1) gene is synergistically activated by Sox17, FoxC2, and Etv2.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25179465","citation_count":27,"is_preprint":false},{"pmid":"29618782","id":"PMC_29618782","title":"ETV2-TET1/TET2 Complexes Induce Endothelial Cell-Specific Robo4 Expression via Promoter Demethylation.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29618782","citation_count":26,"is_preprint":false},{"pmid":"24762086","id":"PMC_24762086","title":"Sox7 is regulated by ETV2 during cardiovascular development.","date":"2014","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/24762086","citation_count":26,"is_preprint":false},{"pmid":"25267199","id":"PMC_25267199","title":"OVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25267199","citation_count":25,"is_preprint":false},{"pmid":"28108843","id":"PMC_28108843","title":"ETS transcription factors Etv2 and Fli1b are required for tumor angiogenesis.","date":"2017","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28108843","citation_count":25,"is_preprint":false},{"pmid":"25780560","id":"PMC_25780560","title":"ETV2 expression increases the efficiency of primitive endothelial cell derivation from human embryonic stem cells.","date":"2015","source":"Cell regeneration (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25780560","citation_count":25,"is_preprint":false},{"pmid":"28461595","id":"PMC_28461595","title":"ETV2/ER71 regulates hematopoietic regeneration by promoting hematopoietic stem cell proliferation.","date":"2017","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28461595","citation_count":23,"is_preprint":false},{"pmid":"28066054","id":"PMC_28066054","title":"Etv2 IS A MASTER REGULATOR OF HEMATOENDOTHELIAL LINEAGES.","date":"2016","source":"Transactions of the American Clinical and Climatological Association","url":"https://pubmed.ncbi.nlm.nih.gov/28066054","citation_count":23,"is_preprint":false},{"pmid":"30755583","id":"PMC_30755583","title":"In vivo transduction of ETV2 improves cardiac function and induces vascular regeneration following myocardial infarction.","date":"2019","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30755583","citation_count":23,"is_preprint":false},{"pmid":"33522307","id":"PMC_33522307","title":"Upregulation of ETV2 Expression Promotes Endothelial Differentiation of Human Dental Pulp Stem Cells.","date":"2021","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/33522307","citation_count":22,"is_preprint":false},{"pmid":"32628937","id":"PMC_32628937","title":"Ets1 functions partially redundantly with Etv2 to promote embryonic vasculogenesis and angiogenesis in zebrafish.","date":"2020","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32628937","citation_count":22,"is_preprint":false},{"pmid":"31864907","id":"PMC_31864907","title":"cAMP/EPAC Signaling Enables ETV2 to Induce Endothelial Cells with High Angiogenesis Potential.","date":"2019","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31864907","citation_count":22,"is_preprint":false},{"pmid":"36195958","id":"PMC_36195958","title":"ETV2 promotes osteogenic differentiation of human dental pulp stem cells through the ERK/MAPK and PI3K-Akt signaling pathways.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36195958","citation_count":21,"is_preprint":false},{"pmid":"36927793","id":"PMC_36927793","title":"ETV2/ER71, the key factor leading the paths to vascular regeneration and angiogenic reprogramming.","date":"2023","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36927793","citation_count":20,"is_preprint":false},{"pmid":"23606617","id":"PMC_23606617","title":"Etv2 rescues Flk1 mutant embryoid bodies.","date":"2013","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/23606617","citation_count":20,"is_preprint":false},{"pmid":"26565905","id":"PMC_26565905","title":"The Etv2-miR-130a Network Regulates Mesodermal Specification.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26565905","citation_count":20,"is_preprint":false},{"pmid":"28419336","id":"PMC_28419336","title":"IP3R-mediated Ca2+ signals govern hematopoietic and cardiac divergence of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway.","date":"2017","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28419336","citation_count":20,"is_preprint":false},{"pmid":"27488544","id":"PMC_27488544","title":"Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia.","date":"2016","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27488544","citation_count":20,"is_preprint":false},{"pmid":"29669933","id":"PMC_29669933","title":"Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29669933","citation_count":19,"is_preprint":false},{"pmid":"35649376","id":"PMC_35649376","title":"Differential Etv2 threshold requirement for endothelial and erythropoietic development.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35649376","citation_count":17,"is_preprint":false},{"pmid":"33115267","id":"PMC_33115267","title":"ETV2 (Ets Variant Transcription Factor 2)-Rhoj Cascade Regulates Endothelial Progenitor Cell Migration During Embryogenesis.","date":"2020","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33115267","citation_count":17,"is_preprint":false},{"pmid":"29232705","id":"PMC_29232705","title":"Etv2-miR-130a-Jarid2 cascade regulates vascular patterning during embryogenesis.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29232705","citation_count":17,"is_preprint":false},{"pmid":"35333649","id":"PMC_35333649","title":"Hemogenic and aortic endothelium arise from a common hemogenic angioblast precursor and are specified by the Etv2 dosage.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35333649","citation_count":17,"is_preprint":false},{"pmid":"35370273","id":"PMC_35370273","title":"Transient ETV2 Expression Promotes the Generation of Mature Endothelial Cells from Human Pluripotent Stem Cells.","date":"2022","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/35370273","citation_count":16,"is_preprint":false},{"pmid":"31534512","id":"PMC_31534512","title":"ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31534512","citation_count":15,"is_preprint":false},{"pmid":"35864091","id":"PMC_35864091","title":"Etv2 regulates enhancer chromatin status to initiate Shh expression in the limb bud.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35864091","citation_count":15,"is_preprint":false},{"pmid":"29753018","id":"PMC_29753018","title":"ETS transcription factor Etsrp / Etv2 is required for lymphangiogenesis and directly regulates vegfr3 / flt4 expression.","date":"2018","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29753018","citation_count":15,"is_preprint":false},{"pmid":"24984259","id":"PMC_24984259","title":"Transcriptional inhibition of etv2 expression is essential for embryonic cardiac development.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24984259","citation_count":14,"is_preprint":false},{"pmid":"38969874","id":"PMC_38969874","title":"A streamlined method to generate endothelial cells from human pluripotent stem cells via transient doxycycline-inducible ETV2 activation.","date":"2024","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/38969874","citation_count":14,"is_preprint":false},{"pmid":"36923254","id":"PMC_36923254","title":"ETV2 and VEZF1 interaction and regulation of the hematoendothelial lineage during embryogenesis.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36923254","citation_count":12,"is_preprint":false},{"pmid":"31278282","id":"PMC_31278282","title":"Etv2 transcriptionally regulates Yes1 and promotes cell proliferation during embryogenesis.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31278282","citation_count":12,"is_preprint":false},{"pmid":"31744543","id":"PMC_31744543","title":"ETV2/ER71 regulates the generation of FLK1+ cells from mouse embryonic stem cells through miR-126-MAPK signaling.","date":"2019","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31744543","citation_count":12,"is_preprint":false},{"pmid":"24956419","id":"PMC_24956419","title":"Distinct regulation of the anterior and posterior myeloperoxidase expression by Etv2 and Gata1 during primitive Granulopoiesis in zebrafish.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24956419","citation_count":11,"is_preprint":false},{"pmid":"31705559","id":"PMC_31705559","title":"Zebrafish etv2 knock-in line labels vascular endothelial and blood progenitor cells.","date":"2019","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/31705559","citation_count":10,"is_preprint":false},{"pmid":"37330911","id":"PMC_37330911","title":"ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37330911","citation_count":9,"is_preprint":false},{"pmid":"33814416","id":"PMC_33814416","title":"ER71/ETV2 Promotes Hair Regeneration from Chemotherapeutic Drug-Induced Hair Loss by Enhancing Angiogenesis.","date":"2021","source":"Biomolecules & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/33814416","citation_count":9,"is_preprint":false},{"pmid":"30953479","id":"PMC_30953479","title":"Clec14a genetically interacts with Etv2 and Vegf signaling during vasculogenesis and angiogenesis in zebrafish.","date":"2019","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/30953479","citation_count":9,"is_preprint":false},{"pmid":"28424975","id":"PMC_28424975","title":"ETV-2 activated proliferation of endothelial cells and attenuated acute hindlimb ischemia in mice.","date":"2017","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/28424975","citation_count":8,"is_preprint":false},{"pmid":"39075623","id":"PMC_39075623","title":"BCL6B-dependent suppression of ETV2 hampers endothelial cell differentiation.","date":"2024","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/39075623","citation_count":7,"is_preprint":false},{"pmid":"33359164","id":"PMC_33359164","title":"Biallelic variants in ETV2 in a family with congenital heart defects, vertebral abnormalities and preaxial polydactyly.","date":"2021","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33359164","citation_count":7,"is_preprint":false},{"pmid":"28026128","id":"PMC_28026128","title":"ETS transcription factor ETV2/ER71/Etsrp in hematopoietic and vascular development, injury, and regeneration.","date":"2017","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/28026128","citation_count":6,"is_preprint":false},{"pmid":"40495012","id":"PMC_40495012","title":"Pioneer factor ETV2 safeguards endothelial cell specification by recruiting the repressor REST to restrict alternative lineage commitment.","date":"2025","source":"Nature cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/40495012","citation_count":6,"is_preprint":false},{"pmid":"32075417","id":"PMC_32075417","title":"Etv2- and Fli1-Induced Vascular Progenitor Cells Enhance Functional Recovery in Ischemic Vascular Disease Model-Brief Report.","date":"2020","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32075417","citation_count":6,"is_preprint":false},{"pmid":"35531980","id":"PMC_35531980","title":"Endocardial identity is established during early somitogenesis by Bmp signalling acting upstream of npas4l and etv2.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35531980","citation_count":6,"is_preprint":false},{"pmid":"38503291","id":"PMC_38503291","title":"SOX17/ETV2 improves the direct reprogramming of adult fibroblasts to endothelial cells.","date":"2024","source":"Cell reports methods","url":"https://pubmed.ncbi.nlm.nih.gov/38503291","citation_count":6,"is_preprint":false},{"pmid":"40134129","id":"PMC_40134129","title":"ETV2 Overexpression Promotes Efficient Differentiation of Pluripotent Stem Cells to Endothelial Cells.","date":"2025","source":"Biotechnology and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/40134129","citation_count":5,"is_preprint":false},{"pmid":"23795570","id":"PMC_23795570","title":"Role of Etv2-positive cells in the remodeling morphogenesis during vascular development.","date":"2013","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23795570","citation_count":5,"is_preprint":false},{"pmid":"32910224","id":"PMC_32910224","title":"FGF primes angioblast formation by inducing ETV2 and LMO2 via FGFR1/BRAF/MEK/ERK.","date":"2020","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/32910224","citation_count":5,"is_preprint":false},{"pmid":"37373052","id":"PMC_37373052","title":"ETV2 Enhances CXCL5 Secretion from Endothelial Cells, Leading to the Promotion of Vascular Smooth Muscle Cell Migration.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37373052","citation_count":5,"is_preprint":false},{"pmid":"28466428","id":"PMC_28466428","title":"Extracellular vesicles of ETV2 transfected fibroblasts stimulate endothelial cells and improve neovascularization in a murine model of hindlimb ischemia.","date":"2017","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28466428","citation_count":5,"is_preprint":false},{"pmid":"36463633","id":"PMC_36463633","title":"Generation of a doxycycline-inducible ETV2 expression cell line using PiggyBac transposase system.","date":"2022","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36463633","citation_count":4,"is_preprint":false},{"pmid":"36512477","id":"PMC_36512477","title":"ETV2 Upregulation Marks the Specification of Early Cardiomyocytes and Endothelial Cells During Co-differentiation.","date":"2023","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/36512477","citation_count":4,"is_preprint":false},{"pmid":"35181635","id":"PMC_35181635","title":"ETV2 regulates PARP-1 binding protein to induce ER stress-mediated death in tuberin-deficient cells.","date":"2022","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/35181635","citation_count":4,"is_preprint":false},{"pmid":"29697486","id":"PMC_29697486","title":"ETS transcription factor ETV2/ER71/Etsrp in haematopoietic regeneration.","date":"2018","source":"Current opinion in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/29697486","citation_count":3,"is_preprint":false},{"pmid":"35883376","id":"PMC_35883376","title":"One-Step In Vitro Generation of ETV2-Null Pig Embryos.","date":"2022","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/35883376","citation_count":3,"is_preprint":false},{"pmid":"39811655","id":"PMC_39811655","title":"ETV2/ER71 regulates hematovascular lineage generation and vascularization through an H3K9 demethylase, KDM4A.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/39811655","citation_count":2,"is_preprint":false},{"pmid":"39391221","id":"PMC_39391221","title":"PPARγ/ETV2 axis regulates endothelial-to-mesenchymal transition in pulmonary hypertension.","date":"2024","source":"Pulmonary circulation","url":"https://pubmed.ncbi.nlm.nih.gov/39391221","citation_count":2,"is_preprint":false},{"pmid":"34146583","id":"PMC_34146583","title":"Morphological characterization of Etv2 vascular explants using fractal analysis and atomic force microscopy.","date":"2021","source":"Microvascular research","url":"https://pubmed.ncbi.nlm.nih.gov/34146583","citation_count":2,"is_preprint":false},{"pmid":"35096818","id":"PMC_35096818","title":"Gfi1aa/Lsd1 Facilitates Hemangioblast Differentiation Into Primitive Erythrocytes by Targeting etv2 and sox7 in Zebrafish.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35096818","citation_count":2,"is_preprint":false},{"pmid":"31990674","id":"PMC_31990674","title":"ETV2-null porcine embryos survive to post-implantation following incomplete enucleation.","date":"2020","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31990674","citation_count":2,"is_preprint":false},{"pmid":"41272813","id":"PMC_41272813","title":"APPswe mutation causes functional deficits in endothelial cells generated by transient ETV2 overexpression in human iPSCs.","date":"2025","source":"Fluids and barriers of the CNS","url":"https://pubmed.ncbi.nlm.nih.gov/41272813","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49100,"output_tokens":11610,"usd":0.160725,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22675,"output_tokens":4525,"usd":0.11325,"stage2_stop_reason":"end_turn"},"total_usd":0.273975,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"ER71 is a constitutively nuclear protein whose intracellular localization depends on a portion of the ETS domain (amino acids 276-315). The N-terminus of ER71 negatively regulates DNA binding, while the C-terminus dramatically enhances DNA binding activity. ER71 possesses a potent N-terminal transactivation domain (amino acids 1-157) and directly activates the matrix metalloproteinase-1 promoter via an E74 site.\",\n      \"method\": \"Deletion mutagenesis, reporter assays, nuclear localization analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro functional characterization with mutagenesis but single lab, single study\",\n      \"pmids\": [\"12087183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TSGA/Jmjd1a interacts with ER71 both in vitro and in vivo; the N-terminus of TSGA and C-terminus of ER71 mediate complex formation. TSGA represses ER71-dependent transcriptional activation of the MMP-1 promoter.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, reporter assay\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reciprocal binding shown in vitro and in vivo, functional consequence demonstrated, single lab\",\n      \"pmids\": [\"16619273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ER71 acts downstream of BMP, Notch, and Wnt signaling to regulate FLK1+ mesoderm specification. Inhibition of BMP, Notch, and Wnt signaling decreased FLK1+ mesoderm and ER71 expression; enforced ER71 expression rescued FLK1+ mesoderm generation blocked by these inhibitors. Er71-deficient mice lacked FLK1 expression and displayed severe blood and vessel defects reminiscent of Flk1 null mice.\",\n      \"method\": \"Embryonic stem cell differentiation, pathway inhibition, genetic knockout, gain-of-function rescue\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple pathway inhibitors, loss-of-function, and gain-of-function rescue, replicated across multiple experimental systems\",\n      \"pmids\": [\"18462699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Human ETV2/ER71 and mouse ER71 are functional orthologs of zebrafish Etsrp. Overexpression of mouse ER71 caused expansion of hemangioblast and vascular endothelial lineages in zebrafish. Etsrp functions cell-autonomously in inducing myeloid lineage, and the choice of endothelial versus myeloid fate depends on combinatorial effects of etsrp, scl, and alk8.\",\n      \"method\": \"Zebrafish overexpression, mosaic analysis, morpholino knockdown\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-autonomous function established by mosaic analysis, multiple orthogonal approaches, replicated across organisms\",\n      \"pmids\": [\"18270322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Etv2 is dispensable for generating primitive Flk-1+/PDGFRα+ mesoderm but required for the progression of these cells into Flk-1+/PDGFRα- vascular/hematopoietic mesoderm. Key downstream targets include Scl, Fli1, and GATA2. Expression of Scl or Fli1 alone could restore HPCs/ECs in Etv2-null background. VEGF potently and rapidly induces Etv2 in Flk-1+ mesoderm.\",\n      \"method\": \"ESC differentiation, Etv2-null embryo analysis, re-expression rescue experiments, gene expression profiling\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — null embryo analysis combined with rescue experiments identifying specific downstream targets, multiple orthogonal approaches\",\n      \"pmids\": [\"21911838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In the absence of ER71, cells that would normally become hematopoietic and endothelial lineages are redirected to cardiac lineages, including cardiomyocytes. ER71-expressing cells give rise to hematopoietic and endothelial lineages in wild-type, but contribute to cardiac lineage in Er71 mutants. ER71 overexpression repressed cardiogenesis.\",\n      \"method\": \"Er71-EYFP transgenic mouse, Er71-Cre genetic fate mapping, FACS, transcriptional profiling, inducible ES/EB system\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic fate mapping with Cre-lox, multiple engineered mouse models, and ESC system, orthogonal methods in single study\",\n      \"pmids\": [\"21989919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Etsrp-expressing vascular endothelial/endocardial progenitors differentiate as cardiomyocytes in the absence of Etsrp function. Etsrp directly induces endocardial nfatc1 expression to regulate endocardial differentiation. Etsrp inhibits myocardial differentiation through a distinct mechanism from endocardial induction. Foxc1a interaction with Etsrp is required to initiate endocardial development but dispensable for inhibition of myocardial differentiation.\",\n      \"method\": \"Zebrafish morpholino knockdown, mutant analysis, lineage tracing\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function combined with direct target identification and dissection of two distinct regulatory mechanisms, replicated in multiple zebrafish models\",\n      \"pmids\": [\"21989916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Foxc1a and Foxc1b directly regulate etsrp expression in angioblasts. ChIP showed Foxc1a/b binding to an enhancer 2.3 kb upstream of etsrp containing a consensus FOX binding site. Combined knockdown of foxc1a/b decreased etsrp expression at early developmental stages.\",\n      \"method\": \"EMSA, ChIP, morpholino knockdown, transgenic reporter analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding demonstrated by EMSA and ChIP, functional consequence shown by knockdown, two orthogonal methods\",\n      \"pmids\": [\"22135404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ER71 specifies Flk-1+PDGFRα- hemangiogenic mesoderm by negatively regulating cardiac and Wnt signaling pathway genes. ER71 inhibits Wnt signaling through VE-cadherin-independent and VE-cadherin-dependent (VE-cadherin/β-catenin/Flk-1 complex formation) mechanisms. Enforced β-catenin rescued cardiogenic mesoderm in the context of ER71 overexpression.\",\n      \"method\": \"ESC differentiation, gain/loss-of-function, β-catenin rescue experiments, gene expression analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genetic approaches establishing epistasis between ER71 and Wnt signaling, rescue experiments, single lab\",\n      \"pmids\": [\"22343916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKA/CREB signaling activates Etv2 transcription to trigger endothelial and hematopoietic cell differentiation. Two CRE sequences in the Etv2 promoter and 5'-UTR were identified; CREB directly binds these CRE sites. Dominant negative CREB completely inhibited PKA-elicited Etv2 expression and EC/HPC induction from ESCs.\",\n      \"method\": \"Promoter analysis, CREB binding confirmation, dominant-negative CREB, PKA inhibition, ex vivo embryo culture\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding demonstrated, functional consequence with dominant-negative approach, validated in vivo in Etv2-Venus knockin mice\",\n      \"pmids\": [\"22267325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SRY binds to and activates the Er71 promoter. In turn, ER71 binds to the Sox9 promoter and activates Sox9 transcription; mutation of the ER71 binding site suppressed this activation. SOX9 also binds the Er71 promoter, and Sox9 downregulation reduced Er71 levels, forming a positive autoregulatory loop between ER71 and SOX9 in testis.\",\n      \"method\": \"Promoter binding assays, site-directed mutagenesis, dominant-negative ER71, ChIP, luciferase reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding by ChIP and mutagenesis, functional consequence demonstrated with dominant-negative and knockdown, multiple orthogonal approaches\",\n      \"pmids\": [\"22613723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ETV2 is required for the formation of hemogenic endothelium; ETV2 deficiency results in a complete absence of hemogenic endothelium in differentiating ES cells and gastrulating embryos.\",\n      \"method\": \"ETV2::GFP transgenic mouse, ES cell differentiation, FACS sorting, in vivo embryo analysis\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic reporter combined with ETV2 null analysis, two orthogonal systems (ES cells and embryos)\",\n      \"pmids\": [\"22733530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ETV2 acts prior to or at the time of FLK1 expression in mesodermal precursors. ETV2 re-expression in Etv2-/- Flk1-negative precursors drives hematopoiesis specification and switches on SCL, GATA2, and FLI1 expression. SCL re-expression in Etv2-/- cells fully rescues hematopoiesis, while FLI1 or GATA2 re-expression provides only limited rescue.\",\n      \"method\": \"Cre-mediated ETV2 deletion, Flk1-Cre, ESC differentiation rescue experiments\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout combined with systematic rescue experiments identifying hierarchy of downstream targets, two independent laboratories (replicated findings)\",\n      \"pmids\": [\"22570122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Etv2 expression alone is sufficient to transdifferentiate fast skeletal muscle cells into functional blood vessels in vivo. The canonical Wnt pathway is important for induction of transdifferentiation, while the VEGF pathway provides a maturation signal for endothelial fate. Mammalian myoblasts, but not other cell types examined, induced vascular gene expression upon Etv2 overexpression.\",\n      \"method\": \"Heat shock-inducible Etv2 zebrafish transgene, time-lapse imaging, lineage tracing, immunostaining, pharmacological/transgenic/morpholino approaches\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — lineage tracing confirms muscle-to-endothelial transdifferentiation, time-lapse imaging, multiple pathway dissection approaches in single rigorous study\",\n      \"pmids\": [\"23853546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Forced expression of Etv2 rescued both hematopoietic and endothelial potential of differentiating Flk1-/- and Etv2-/- cells, whereas forced Flk1 expression rescued only Flk1-/- but not Etv2-/- cells. This demonstrates that Etv2 functions downstream of or parallel to Flk1 and that disruption of Etv2 expression is responsible for early phenotypes of Flk1 mutant embryos.\",\n      \"method\": \"Inducible viral rescue of knockout ESCs, EB differentiation\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis established by differential rescue experiments in two distinct null backgrounds, single lab\",\n      \"pmids\": [\"23606617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Post-transcriptional repression by let-7 family microRNAs contributes to Etv2 downregulation during vascular development. The etv2 3'UTR contains binding sites for let-7 miRNAs; ectopic let-7a repressed the etv2 3'UTR and blocked endogenous Etv2 protein expression. Etv2 protein persisted in maternal-zygotic dicer1 mutant zebrafish embryos.\",\n      \"method\": \"Inducible Etv2 knockdown, 3'UTR reporter assays, miRNA overexpression, dicer1 mutant analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3'UTR reporter assay combined with dicer mutant validation, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"24036310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Etv2 interacts with Gata2 in vitro and in vivo; the interaction is mediated by the Ets and Gata domains. Co-expression of Gata2 augments Etv2 activity in promoting endothelial and hematopoietic lineage differentiation. Etv2 and Gata2 both bind the Spi1 promoter in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, ChIP, embryoid body differentiation\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and GST pulldown with domain mapping, in vivo ChIP, functional co-expression data, multiple orthogonal methods\",\n      \"pmids\": [\"24583263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Etv2 binds to conserved Ets-binding sites in the Fli1 promoter and governs Fli1 expression. After Etv2 expression ceases at midgestation, Fli1 protein itself binds those same Ets-binding sites in a positive autoregulatory loop, maintaining Fli1 expression and selective Etv2-regulated endothelial genes. Fli1 also binds the Tie2 promoter/enhancer to control its expression beyond midgestation.\",\n      \"method\": \"ChIP, promoter binding assays, loss/gain-of-function, endothelial cell survival assays\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding by ChIP with functional consequence, ETS switching mechanism demonstrated, multiple molecular and cellular approaches\",\n      \"pmids\": [\"24727028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"OVOL2, a C2H2 zinc finger protein, directly interacts with ER71/ETV2 in the nucleus. OVOL2 enhances ER71-mediated activation of the Flk1 promoter. Co-expression of ER71 and OVOL2 augmented FLK1+, endothelial, and hematopoietic cell generation from differentiating ESCs.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, ESC differentiation, shRNA knockdown\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with functional reporter assay and shRNA validation, single lab\",\n      \"pmids\": [\"25267199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ETV2 directly regulates Sox7 by binding ETV2 binding elements in the Sox7 upstream regulatory region and activating transcription. SOX7 overexpression mimics ETV2 in increasing endothelial progenitor cells, while Sox7 knockdown blocks ETV2-induced endothelial progenitor formation and angiogenic sprouting.\",\n      \"method\": \"ChIP, luciferase reporter assay, shRNA knockdown, embryoid body differentiation\",\n      \"journal\": \"Stem cells and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct binding by ChIP with mutagenesis-style reporter confirmation, functional epistasis by rescue/block, single lab\",\n      \"pmids\": [\"24762086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FoxC2 and Etv2 cooperatively activate a FOX:ETS composite motif in the ECE1 arterial enhancer. Additionally, Sox17 binds a conserved SOX site in the same enhancer, and the ECE1 enhancer is cooperatively activated by combinatorial action of FoxC2, Etv2, and Sox17.\",\n      \"method\": \"Transgenic mouse reporter assay, EMSA, promoter mutagenesis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vivo reporter combined with in vitro binding, cooperative activation demonstrated with mutagenesis, single lab\",\n      \"pmids\": [\"25179465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ETV2 binds to enhancers that specify hematopoietic and endothelial cell lineages (global ChIP-seq). ETV2 activates other Ets genes (Fli1, Erg, etc.), establishing an ETS hierarchy, and the hematopoietic/endothelial program initiated by ETV2 is maintained by other ETS factors through an ETS switching mechanism. The hemangiogenic progenitor population (FLK1highPDGFRα-) is exclusively sensitive to ETV2-dependent FLK1 signaling.\",\n      \"method\": \"ChIP-seq, ESC differentiation, germ-line and conditional knockout mouse studies\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genome-wide ChIP-seq with multiple genetic models (in vitro and in vivo), multiple orthogonal methods establishing ETS hierarchy mechanism\",\n      \"pmids\": [\"25802403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Etv2 and Fli1b share the same transcriptional targets and bind to the same ETS sites, as shown by RNA-Seq and ChIP. Etv2 and Fli1b function redundantly during late vasculogenesis and early embryonic angiogenesis, with two distinct phases: Etv2 alone required for early vasculogenesis, Etv2 and Fli1b redundant during late vasculogenesis/early angiogenesis.\",\n      \"method\": \"Zebrafish mutants, RNA-Seq, ChIP, photoactivatable morpholinos, overexpression\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — shared target identification by ChIP and RNA-Seq combined with genetic epistasis, multiple orthogonal approaches in single study\",\n      \"pmids\": [\"25722433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Etv2 directly activates miR-130a. miR-130a promotes the endothelial program at the expense of cardiac program by directly suppressing Pdgfra expression and blocking Pdgfra signaling. CRISPR/Cas9 knockout of miR-130a reduced the endothelial program without affecting hematopoiesis.\",\n      \"method\": \"ChIP, CRISPR/Cas9 knockout, gain-of-function, Dicer ablation in Etv2-expressing cells, ESC/EB differentiation\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct ChIP target validation combined with CRISPR knockout and rescue experiments, multiple orthogonal approaches\",\n      \"pmids\": [\"26565905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Endothelial ETV2 is required for injury-induced vascular regeneration. Etv2 expression is reactivated in endothelial cells after injury (but not detectable at steady-state). ETV2 upregulates Flk1/VEGFR2 expression after injury; Flk1 expression rescued angiogenesis defects in endothelial Etv2 conditional knockout mice. Etv2+/-;Flk1+/- double heterozygous mice showed more severe ischemic injury response, establishing epistatic interaction between ETV2 and FLK1.\",\n      \"method\": \"Endothelial-specific conditional knockout, ischemia models, lentiviral rescue, double heterozygous epistasis\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with multiple ischemia models, lentiviral rescue, and genetic epistasis, multiple orthogonal approaches\",\n      \"pmids\": [\"26586661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LSD1/KDM1A promotes hematopoietic commitment of hemangioblasts through downregulation of Etv2. Hematopoietic defects in lsd1 mutant zebrafish were rescued by knockdown of etv2, placing LSD1 upstream of Etv2 in hemangioblast fate commitment.\",\n      \"method\": \"Zebrafish mutant screen, morpholino knockdown rescue, genetic epistasis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via rescue experiment, morpholino knockdown in mutant background, single lab\",\n      \"pmids\": [\"26512114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Vegf signaling promotes vascular endothelial differentiation by modulating Etv2 expression. Vegfr inhibition reduced etv2 expression; Vegfaa overexpression expanded etv2 expression. Vascular-specific overexpression of etv2 in Vegfr-inhibited embryos rescued defects in vascular endothelial differentiation, placing Etv2 downstream of Vegf signaling.\",\n      \"method\": \"Chemical Vegfr inhibition, genetic mutants, overexpression rescue, zebrafish embryos\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and pharmacological approaches combined with rescue experiment establishing Etv2 as downstream target of Vegf, replicated across chemical and genetic models\",\n      \"pmids\": [\"28279709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ETV2 directly binds promoter region of Rhoj, serving as upstream transcriptional regulator of cell migration. ETV2 overexpression enhanced cell migration in ESCs, embryoid bodies, and fibroblasts; Etv2 knockout led to migratory defects of angioblasts in developing embryos. shRNA knockdown of Rhoj caused migration defects partially rescued by ETV2 overexpression.\",\n      \"method\": \"ChIP-seq, ATAC-seq, RNAseq, migration assays, Etv2 knockout embryos, shRNA knockdown rescue\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP-seq and ATAC-seq with direct functional validation in multiple cell systems and in vivo, multiple orthogonal methods in single study\",\n      \"pmids\": [\"33115267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IP3R-mediated Ca2+ signals govern hematopoietic versus cardiac fate of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway. Constitutively active NFATc3 rescued Etv2 expression in IP3R-knockout cells. NFATc3 directly targets Etv2 via an evolutionarily conserved cis-element.\",\n      \"method\": \"IP3R triple knockout ESCs, Ca2+ manipulation, calcineurin activation, NFATc3 constitutively active expression, ChIP\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway epistasis established with knockout and rescue, direct binding by ChIP, single lab\",\n      \"pmids\": [\"28419336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Foxh1, in part through Eomes, is critical for FLK1+ mesoderm formation. Hemangiogenic fate is specified through a threshold-dependent mechanism in which VEGF-FLK1 signaling plays an instructive role by promoting Etv2 threshold expression.\",\n      \"method\": \"Genome-wide CRISPR screen, Brachyury/Etv2/Scl reporter ESC lines, transcriptome analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased genome-wide CRISPR screen with reporter lines and transcriptome validation, establishes upstream pathway, single lab\",\n      \"pmids\": [\"28912455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ETV2 is sufficient and necessary for transdifferentiation of CD133+/Nestin+ GBM/neural stem cells to endothelial lineage. ChIP-Seq combined with gain-of-function RNA-Seq showed that ETV2 activates vascular genes and represses proneural genes to direct endo-transdifferentiation. This process is VEGF-A independent.\",\n      \"method\": \"ChIP-Seq, RNA-Seq, gain/loss-of-function experiments\",\n      \"journal\": \"Signal transduction and targeted therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP-seq and RNA-seq combined with functional gain/loss-of-function, single lab\",\n      \"pmids\": [\"29527330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ETV2 directly binds promoter/enhancer regions of Vegfr3/Flt4 and lymphatic marker Lyve1, promoting their expression. Etv2 inhibition at 1 dpf inhibited lymphangiogenesis while blood vessel development was unaffected, and lymphatic progenitors failed to respond to Vegfc signaling in Etv2-deficient embryos.\",\n      \"method\": \"Photoactivatable morpholinos, ChIP-seq, luciferase reporter assays, zebrafish embryos\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP-seq with direct reporter validation and inducible knockdown, multiple orthogonal methods in single study\",\n      \"pmids\": [\"29753018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"ETV2 directly interacts with TET1 and TET2 methylcytosine-converting enzymes. ETV2 binds ETS motifs in the Robo4 promoter and activates expression. ETV2-TET1/TET2 complexes demethylate the Robo4 promoter in non-endothelial cells, providing a mechanism for EC-specific gene expression via promoter demethylation.\",\n      \"method\": \"Co-immunoprecipitation, reporter assay, adenoviral expression, methylation analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP of complex with functional consequence in DNA demethylation, two orthogonal approaches, single lab\",\n      \"pmids\": [\"29618782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"cAMP/EPAC/RAP1 signaling facilitates ETV2-mediated endothelial transdifferentiation. ChIP-seq showed majority of ETV2 targets in human fibroblasts are related to vasculature development and Rap1 signaling. Activation of cAMP/EPAC/RAP1 axis improved efficiency and quality of ETV2-induced endothelial cells.\",\n      \"method\": \"ChIP-seq, pharmacological pathway activation, in vivo and in vitro functional assays\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — ChIP-seq with pharmacological pathway validation, functional assessment, single lab\",\n      \"pmids\": [\"31864907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ETV2 transcriptionally regulates Yes1 as a direct upstream regulator during embryogenesis. Doxycycline-mediated Etv2 induction increased Yes1 in a dose-dependent manner. Etv2 induction also caused ~2.5-fold increase in cellular proliferation, associated with upregulation of cell cycle genes E2f4 and Ccne1.\",\n      \"method\": \"ChIP-seq analysis, RNAseq, EdU-incorporation, doxycycline-inducible Etv2 ES/EB system, single-cell RNA-seq\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP-seq identifying direct binding to Yes1 promoter with dose-dependent expression validation and null EB confirmation, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"31278282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ETV2/ER71 directly induces miR-126, which positively regulates FLK1+ cell generation by activating the MAPK pathway through targeting SPRED1. JUN/FOS activate the FLK1 enhancer through AP1 binding sequences downstream of this miR-126-MAPK axis.\",\n      \"method\": \"miRNA sequencing, ChIP-PCR, signaling pathway analysis\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP-PCR establishing direct miR-126 target with downstream MAPK pathway validation, single lab\",\n      \"pmids\": [\"31744543\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ETV2 functions as a pioneer factor that binds nucleosomal DNA and recruits BRG1. BRG1 recruitment remodels chromatin around endothelial genes and helps maintain an open configuration, resulting in increased H3K27ac deposition, thereby regulating endothelial development.\",\n      \"method\": \"Multi-omics (ATAC-seq, ChIP-seq), engineered ESC differentiation and reprogramming models, nucleosome binding assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — nucleosome binding shown directly, BRG1 recruitment mechanism validated, chromatin remodeling quantified by multiple epigenomic methods in a rigorous multi-omics study\",\n      \"pmids\": [\"35550615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ETV2 functions as a pioneer transcription factor initiating Shh expression during limb development by changing chromatin status of the ZRS limb enhancer. ETV2 binds nucleosome-occupied ZRS, causes nucleosomal displacement at ETS binding site clusters, and is antagonized by ETV4/5 repressors. Known human polydactyl mutations introduce novel ETV2 binding sites in the ZRS.\",\n      \"method\": \"Etv2 conditional inactivation, Etv2 overexpression in limb buds, ATAC-seq, ChIP-seq, luciferase reporter assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — pioneer factor activity directly demonstrated with chromatin accessibility assays and nucleosome displacement analysis, combined with gain/loss-of-function in vivo, multiple orthogonal methods\",\n      \"pmids\": [\"35864091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Etv2 dosage determines fate between hemogenic and aortic endothelium from a common hemogenic angioblast precursor. High Etv2 dosage specifies hemogenic endothelial cells while low Etv2 specifies conventional endothelium.\",\n      \"method\": \"Photoconvertible labeling, time-lapse imaging, single-cell RNA-sequencing, zebrafish\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — lineage tracing with photoconversion combined with scRNA-seq, single lab, two orthogonal approaches\",\n      \"pmids\": [\"35333649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Etv2 functions directly in a coherent feedforward transcriptional network for vascular endothelial development. Low-level Etv2 expression is sufficient to induce and sustain the endothelial GRN, whereas a significantly higher threshold of Etv2 is required to initiate and sustain erythropoietic development. Etv2 induces the erythropoietic GRN indirectly via activation of Tal1.\",\n      \"method\": \"Hypomorphic Etv2 mutant analysis, gene regulatory network analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — hypomorphic mutant provides dosage-sensitive mechanistic insight, identifies Tal1 as indirect effector, single lab\",\n      \"pmids\": [\"35649376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Bmp signalling acts upstream of etv2 in regulating endocardial identity in zebrafish. Overactivation of Bmp signalling was unable to restore endocardial expression in etv2 mutants, but overexpression of etv2 rescued endocardial expression upon Bmp inhibition, establishing etv2 downstream of Bmp.\",\n      \"method\": \"Zebrafish etv2 and npas4l mutants, Bmp gain/loss of function, epistasis experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with reciprocal rescue experiments, single lab\",\n      \"pmids\": [\"35531980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ETV2 directly interacts with VEZF1 (vascular endothelial zinc finger 1), as demonstrated by yeast two-hybrid, co-immunoprecipitation, and GST pulldown. VEZF1 co-activates ETV2-dependent Flt1 promoter activity. VEZF1 binds the Flt1 promoter in vitro and in vivo (EMSA and ChIP).\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, GST pulldown, luciferase reporter, EMSA, ChIP, Vezf1 knockout ESCs\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct interaction confirmed by three independent binding assays, functional consequence by reporter and knockout, multiple orthogonal methods in single study\",\n      \"pmids\": [\"36923254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment. ETV2 binding at hematoendothelial regulator genes precedes transcriptional activation; the shift from ETV2 binding to ETV2-bound enhancer activation drives hematoendothelial fate commitment.\",\n      \"method\": \"scRNA-seq, ATAC-seq, chromatin accessibility analysis of fate intermediates in mouse\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — chromatin and transcriptome profiling in isolated fate intermediates, mechanistic distinction between binding and activation events, single lab\",\n      \"pmids\": [\"37330911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ETV2 interacts with KDM4A, an H3K9 demethylase; Etv2-null ESCs exhibit enhanced H3K9me3 levels at hematopoietic and endothelial genes. ETV2-mediated transcriptional activation of hematopoietic and endothelial genes depends on KDM4A histone demethylase activity. Cdh5Cre:Kdm4a;Etv2 double conditional knockout mice show more severe vascular regeneration defects than single knockouts.\",\n      \"method\": \"Co-immunoprecipitation, H3K9me3 ChIP, conditional double knockout mice, vascular perfusion assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — Co-IP of complex, direct epigenetic consequence in null cells, genetic validation by double conditional knockout with additive phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"39811655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BCL6B binds the promoter region of ETV2 and suppresses ETV2's transcriptional activity, thereby inhibiting endothelial cell differentiation from hiPSCs. ETV2 overexpression rescued the inhibitory effect of BCL6B overexpression on EC differentiation.\",\n      \"method\": \"Luciferase reporter assay, ChIP-PCR, doxycycline-inducible hiPSC systems, rescue experiments\",\n      \"journal\": \"Stem cell research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter binding by ChIP-PCR with reporter validation and rescue experiment, single lab\",\n      \"pmids\": [\"39075623\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ETV2 pioneer activity both directs EC specification and suppresses alternative fate acquisition. ETV2 recruits the transcriptional repressor REST to repress non-EC lineage genes. GABPA is identified as a cofactor essential for efficient EC specification downstream of ETV2.\",\n      \"method\": \"CUT&RUN, scRNA-seq, scATAC-seq, functional screening, candidate validation\",\n      \"journal\": \"Nature cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — single-cell multi-omics combined with functional screening and candidate validation identifies ETV2-REST recruitment mechanism, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"40495012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Etv2 transcriptionally regulates miR-130a-Jarid2: Etv2-Cre Dicer ablation disrupts vascular patterning. miR-130a directly regulates Jarid2 expression by binding its 3'-UTR, promoting angiogenesis. Jarid2 overexpression leads to defective tube formation; miR-130a morpholino injection in zebrafish results in perturbed vascular patterning with increased Jarid2 levels.\",\n      \"method\": \"Etv2-Cre DicerL/L, miR-130a overexpression, Jarid2 3'UTR binding, zebrafish morpholinos, HUVEC tube formation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — 3'UTR binding validated with morpholino rescue, in vitro and in vivo validation, single lab\",\n      \"pmids\": [\"29232705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PPARγ transcriptionally activates the ETV2 promoter. Endothelial PPARγ overexpression increases ETV2 expression and endothelial markers, while PPARγ knockout decreases ETV2 expression. Etv2 haploinsufficient mice spontaneously developed pulmonary hypertension and right ventricular hypertrophy with increased EndoMT markers.\",\n      \"method\": \"Promoter reporter assay, conditional knockout/overexpression mouse models, EndoMT model\",\n      \"journal\": \"Pulmonary circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter activation confirmed with matching in vivo genetic models, single lab\",\n      \"pmids\": [\"39391221\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ETV2/ER71 is a pioneer ETS transcription factor that acts as a master regulator of hematoendothelial lineage specification: it binds nucleosomal DNA at closed chromatin, recruits chromatin remodelers (BRG1, KDM4A) and the repressor REST to simultaneously open endothelial/hematopoietic gene enhancers and silence alternative lineage genes; it is activated downstream of BMP/Notch/Wnt, VEGF-FLK1, PKA/CREB, and Ca2+-calcineurin-NFATc3 signals, cooperates with co-factors including GATA2, OVOL2, FoxC2, VEZF1, and SOX17 on target enhancers, establishes an ETS hierarchy by directly activating Fli1, Scl, GATA2, and Sox7, and is itself subject to post-transcriptional repression by let-7 microRNAs; its transient expression is critical, as persistent ETV2 perturbs vascular development, while reactivation after injury drives vascular regeneration via upregulation of FLK1/VEGFR2.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ETV2/ER71 is a pioneer ETS transcription factor that acts as a master regulator of hematoendothelial lineage specification, governing the progression of FLK1+ mesoderm into vascular and hematopoietic fates while suppressing alternative cardiac fate [#2, #4, #5]. As a pioneer factor it binds nucleosomal DNA at otherwise closed chromatin, displaces nucleosomes at clustered ETS sites, and recruits the BRG1 chromatin remodeler to open and maintain endothelial gene enhancers with increased H3K27ac [#36, #37]. It primes hematoendothelial enhancers ahead of transcriptional activation, and the transition from binding to enhancer activation drives fate commitment [#42]. ETV2 partners with chromatin- and DNA-modifying enzymes—the H3K9 demethylase KDM4A to relieve repressive H3K9me3 at target genes, and TET1/TET2 to demethylate promoters such as Robo4 for endothelial-specific expression—and it recruits the repressor REST to silence non-endothelial lineage genes [#43, #32, #45]. ETV2 establishes an ETS hierarchy by directly activating downstream regulators including Scl/Tal1, Fli1, GATA2, Erg, and Sox7, with the program subsequently maintained by Fli1 through ETS switching after ETV2 expression ceases [#21, #4, #17, #19]. It cooperates with co-factors GATA2, OVOL2, FoxC2/Sox17, and VEZF1 on target enhancers to drive endothelial and hematopoietic gene activation [#16, #18, #20, #41]. ETV2 is activated downstream of BMP/Notch/Wnt, VEGF-FLK1, PKA/CREB, and calcineurin–NFATc3 signaling, and it dose-dependently partitions endothelial versus hematopoietic/hemogenic fate [#2, #26, #9, #28, #38, #39]. Its expression is transient, terminated post-transcriptionally by let-7 microRNAs, and its reactivation in endothelium after injury drives vascular regeneration via upregulation of FLK1/VEGFR2 [#15, #24].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established the basic molecular architecture of ER71 as a nuclear ETS transcriptional activator before its developmental role was known.\",\n      \"evidence\": \"Deletion mutagenesis and reporter assays mapping localization, DNA-binding, and transactivation domains on the MMP-1 promoter\",\n      \"pmids\": [\"12087183\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No developmental or lineage function identified\", \"MMP-1 target not connected to vascular biology\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified the first ER71 protein partner, showing its activity is subject to negative regulation by an interacting protein.\",\n      \"evidence\": \"Reciprocal in vitro and in vivo binding with TSGA/Jmjd1a plus reporter repression\",\n      \"pmids\": [\"16619273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional relevance to lineage specification not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined ETV2 as a master mesodermal regulator downstream of BMP/Notch/Wnt and conserved across vertebrates, answering where it sits in lineage specification.\",\n      \"evidence\": \"ESC differentiation with pathway inhibition/rescue, mouse knockout, and zebrafish ortholog overexpression/mosaic analysis\",\n      \"pmids\": [\"18462699\", \"18270322\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin targets not yet identified\", \"Mechanism of transcriptional activation undefined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved the precise developmental window and downstream effectors, showing ETV2 drives FLK1+ mesoderm into vascular/hematopoietic fate while repressing cardiac fate.\",\n      \"evidence\": \"Null embryo analysis, genetic fate mapping, and rescue identifying Scl, Fli1, GATA2 as effectors; zebrafish lineage tracing of endocardial nfatc1 induction\",\n      \"pmids\": [\"21911838\", \"21989919\", \"21989916\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether targets are bound directly versus indirectly not fully resolved\", \"Chromatin-level mechanism unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed ETV2 within upstream signaling and feedback circuits, establishing how VEGF-FLK1, PKA/CREB, and Wnt converge on its expression and activity.\",\n      \"evidence\": \"Promoter/CRE binding analysis with dominant-negative CREB, beta-catenin rescue of ER71-suppressed cardiogenesis, GFP reporter null analysis of hemogenic endothelium\",\n      \"pmids\": [\"22343916\", \"22267325\", \"22733530\", \"22570122\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide binding landscape not yet defined\", \"Hierarchy among downstream targets only partially ordered\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Assembled the ETV2 cofactor network and the ETS-switching maintenance mechanism, explaining how a transient factor establishes a self-sustaining program.\",\n      \"evidence\": \"Co-IP/GST pulldown with GATA2 and OVOL2, ChIP of Fli1/Sox7 promoters, FOX:ETS composite enhancer cooperativity with FoxC2/Sox17\",\n      \"pmids\": [\"24583263\", \"25267199\", \"24727028\", \"24762086\", \"25179465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cofactor combinations are selected at specific enhancers unknown\", \"Stoichiometry of complexes undefined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the genome-wide ETV2 enhancer program and its role in injury-induced regeneration, and identified microRNA effectors and upstream epigenetic regulators.\",\n      \"evidence\": \"ChIP-seq establishing ETS hierarchy, conditional knockout/ischemia models with FLK1 rescue and epistasis, miR-130a CRISPR knockout, LSD1 epistasis in zebrafish\",\n      \"pmids\": [\"25802403\", \"25722433\", \"26565905\", \"26586661\", \"26512114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pioneer activity not yet directly demonstrated\", \"Chromatin remodeler partners not yet identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended ETV2 function to cell migration, lymphatic and proliferation programs, and identified additional upstream signals (Ca2+-NFATc3, VEGF, Foxh1) controlling threshold expression.\",\n      \"evidence\": \"ChIP-seq/ATAC-seq of Rhoj and Yes1, IP3R-NFATc3 knockout/rescue, VEGF inhibition/rescue in zebrafish, genome-wide CRISPR screen\",\n      \"pmids\": [\"33115267\", \"28419336\", \"28279709\", \"28912455\", \"29232705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which ETV2 dose is converted to distinct fates unresolved\", \"Direct versus indirect nature of some targets unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrated ETV2 partners with DNA-modifying enzymes and can reprogram non-endothelial cells, revealing an epigenetic basis for endothelial-specific gene activation.\",\n      \"evidence\": \"Co-IP with TET1/TET2 and Robo4 promoter demethylation, ChIP-seq/RNA-seq of GBM/neural stem cell transdifferentiation, ChIP-seq of Vegfr3/Lyve1 lymphatic targets\",\n      \"pmids\": [\"29618782\", \"29527330\", \"29753018\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct demonstration of nucleosome engagement still lacking\", \"Generality of TET recruitment across targets untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Directly established ETV2 as a pioneer factor that engages nucleosomal DNA and recruits chromatin remodelers, the central mechanistic insight unifying its lineage-instructive activity.\",\n      \"evidence\": \"Nucleosome binding assays, ATAC-seq/ChIP-seq with BRG1 recruitment in ESC models, ZRS limb enhancer nucleosome displacement, dosage and feedforward network analysis\",\n      \"pmids\": [\"35550615\", \"35864091\", \"35333649\", \"35649376\", \"35531980\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of pioneer site selection genome-wide unresolved\", \"How BRG1 recruitment is targeted not fully defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Showed ETV2 primes enhancers prior to activation and identified VEZF1 as a direct cofactor, separating chromatin binding from transcriptional output.\",\n      \"evidence\": \"scRNA-seq/ATAC-seq of fate intermediates, yeast two-hybrid/Co-IP/GST pulldown with VEZF1 and Flt1 reporter/knockout\",\n      \"pmids\": [\"37330911\", \"36923254\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trigger converting primed enhancers to active state unknown\", \"Single lab for VEZF1 interaction\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined how ETV2 simultaneously activates target genes via KDM4A demethylation and is itself controlled by transcriptional regulators, with disease relevance in pulmonary hypertension.\",\n      \"evidence\": \"Co-IP and H3K9me3 ChIP with KDM4A double conditional knockouts, BCL6B repression in hiPSCs, PPARgamma promoter activation with Etv2 haploinsufficient pulmonary hypertension model\",\n      \"pmids\": [\"39811655\", \"39075623\", \"39391221\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether KDM4A is broadly required at all ETV2 targets unknown\", \"Causal mechanism linking Etv2 haploinsufficiency to pulmonary hypertension incomplete\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established that ETV2 pioneer activity both activates endothelial genes and actively represses alternative fates by recruiting REST, with GABPA as a downstream cofactor.\",\n      \"evidence\": \"CUT&RUN, scRNA-seq, scATAC-seq, and functional screening with candidate validation\",\n      \"pmids\": [\"40495012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of REST recruitment by ETV2 undefined\", \"Genome-wide repressive target set not exhaustively mapped\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ETV2 dose, cofactor availability, and chromatin state are integrated to deterministically partition individual cells between endothelial, hemogenic, and hematopoietic fates remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No single-cell mechanistic model linking ETV2 dose to fate choice\", \"Rules governing pioneer site selection unknown\", \"Order and dependency of remodeler/demethylase/repressor recruitment undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 17, 21, 36]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 21, 36, 37]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [36, 37]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4, 5, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [17, 21, 36]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [36, 37, 43, 45]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 26, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"GATA2\", \"OVOL2\", \"VEZF1\", \"KDM4A\", \"TET1\", \"TET2\", \"BRG1\", \"REST\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}